- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.51 Å
- Oligo State
- homo-tetramer
- Ligands
- 14 x ACT: ACETATE ION(Non-functional Binders)
- 4 x CL: CHLORIDE ION(Non-functional Binders)
CL.5: 4 residues within 4Å:- Chain A: T.39, E.40
- Chain C: R.159, R.160
Ligand excluded by PLIPCL.11: 4 residues within 4Å:- Chain B: T.39, E.40
- Chain D: R.159, R.160
Ligand excluded by PLIPCL.16: 4 residues within 4Å:- Chain A: R.159, R.160
- Chain C: T.39, E.40
Ligand excluded by PLIPCL.21: 4 residues within 4Å:- Chain B: R.159, R.160
- Chain D: T.39, E.40
Ligand excluded by PLIP- 4 x V74: 3-[3-({[3-(4-carboxyphenoxy)phenyl]methoxy}methyl)phenyl]-1H-indole-2-carboxylic acid(Non-covalent)
V74.6: 13 residues within 4Å:- Chain A: R.29, L.30, E.31, K.33, R.79, C.80, Q.81, E.89, K.91, S.92
- Chain B: K.33
- Ligands: ACT.2, V74.12
17 PLIP interactions:16 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:R.29, A:R.29, A:K.33, A:Q.81, A:Q.81, A:K.91, A:K.91, A:K.91
- Hydrogen bonds: A:R.79, A:Q.81, A:K.91
- Salt bridges: A:K.33, A:K.91, B:K.33
- pi-Cation interactions: A:K.33, A:R.79, A:K.91
V74.12: 13 residues within 4Å:- Chain A: K.33
- Chain B: R.29, L.30, E.31, K.33, R.79, C.80, Q.81, E.89, K.91, S.92
- Ligands: V74.6, ACT.8
17 PLIP interactions:16 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:R.29, B:R.29, B:K.33, B:Q.81, B:Q.81, B:K.91, B:K.91, B:K.91
- Hydrogen bonds: B:R.79, B:Q.81, B:K.91
- Salt bridges: B:K.33, B:K.91, A:K.33
- pi-Cation interactions: B:K.33, B:R.79, B:K.91
V74.17: 11 residues within 4Å:- Chain C: R.29, L.30, E.31, K.33, R.79, C.80, Q.81, K.91, S.92
- Ligands: ACT.14, V74.22
16 PLIP interactions:1 interactions with chain D, 15 interactions with chain C- Salt bridges: D:K.33, C:K.33, C:K.91
- Hydrophobic interactions: C:R.29, C:K.33, C:K.33, C:Q.81, C:Q.81, C:K.91, C:K.91, C:K.91
- Hydrogen bonds: C:Q.81
- Water bridges: C:K.91
- pi-Cation interactions: C:K.33, C:R.79, C:K.91
V74.22: 11 residues within 4Å:- Chain D: R.29, L.30, E.31, K.33, R.79, C.80, Q.81, K.91, S.92
- Ligands: V74.17, ACT.19
16 PLIP interactions:15 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:R.29, D:K.33, D:K.33, D:Q.81, D:Q.81, D:K.91, D:K.91, D:K.91
- Hydrogen bonds: D:Q.81
- Water bridges: D:K.91
- Salt bridges: D:K.33, D:K.91, C:K.33
- pi-Cation interactions: D:K.33, D:R.79, D:K.91
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kozlyuk, N. et al., A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors. Proteins (2021)
- Release Date
- 2021-07-14
- Peptides
- Advanced glycosylation end product-specific receptor: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
BD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.51 Å
- Oligo State
- homo-tetramer
- Ligands
- 14 x ACT: ACETATE ION(Non-functional Binders)
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x V74: 3-[3-({[3-(4-carboxyphenoxy)phenyl]methoxy}methyl)phenyl]-1H-indole-2-carboxylic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kozlyuk, N. et al., A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors. Proteins (2021)
- Release Date
- 2021-07-14
- Peptides
- Advanced glycosylation end product-specific receptor: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
BD
B